|
|
Volumn 19, Issue 24, 2011, Pages 7357-7364
|
|
Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitors
a
a
a
|
|
Author keywords
2H Chromenes; Capsid binders; Chroman 4 ones; Chromans; Rhinoviruses
|
|
Indexed keywords
3 (3 PHENYLALLYLIDENE)CHROMAN;
3 (3 PHENYLALLYLIDENE)CHROMAN 4 ONE;
3 (3 PHENYLPROP 1 EN 1 YL) 2H CHROMENE;
3 (3 PHENYLPROP 2 YN 1 YLIDENE)CHROMAN 4 ONE;
3 [3 (4 CHLOROPHENYL)ALLYLIDENE]CHROMAN;
3 [3 (4 CHLOROPHENYL)ALLYLIDENE]CHROMAN 4 ONE;
3 [3 (4 CHLOROPHENYL)PROP 1 EN 1 YL] 2H CHROMENE;
4 CHROMANONE DERIVATIVE;
4',6 DICHLOROFLAVAN;
6 CHLORO 3 (3 PHENYLALLYLIDENE)CHROMAN;
6 CHLORO 3 (3 PHENYLALLYLIDENE)CHROMAN 4 ONE;
6 CHLORO 3 (3 PHENYLPROP 1 EN 1 YL) 2H CHROMENE;
6 CHLORO 3 (3 PHENYLPROP 2 YN 1 YLIDENE)CHROMAN 4 ONE;
6 CHLORO 3 [3 (4 CHLOROPHENYL)ALLYLIDENE]CHROMAN;
6 CHLORO 3 [3 (4 CHLOROPHENYL)ALLYLIDENE]CHROMAN 4 ONE;
6 CHLORO 3 [3 (4 CHLOROPHENYL)PROP 1 EN 1 YL] 2H CHROMENE;
6 FLUORO 3 (3 PHENYLALLYLIDENE)CHROMAN;
6 FLUORO 3 (3 PHENYLALLYLIDENE)CHROMAN 4 ONE;
CHROMAN DERIVATIVE;
CHROMENE DERIVATIVE;
UNCLASSIFIED DRUG;
ANTIVIRAL ACTIVITY;
ANTIVIRAL SUSCEPTIBILITY;
ARTICLE;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN RHINOVIRUS;
HUMAN RHINOVIRUS 1B;
HUMAN RHINOVIRUS A;
IC 50;
IN VITRO STUDY;
NONHUMAN;
VIRUS CAPSID;
VIRUS INACTIVATION;
VIRUS INHIBITION;
VIRUS REPLICATION;
ANTIVIRAL AGENTS;
BENZOPYRANS;
CAPSID;
CHROMANS;
DRUG DESIGN;
HELA CELLS;
HUMANS;
PICORNAVIRIDAE INFECTIONS;
RHINOVIRUS;
HUMAN RHINOVIRUS 14;
HUMAN RHINOVIRUS 1B;
HUMAN RHINOVIRUS SP.;
MIRIDAE;
RHINOVIRUS;
|
|
EID: 82255192061
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2011.10.060 Document Type: Article |
|
Times cited : (46)
|
|
References (25)
|
